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Aims: To assess the effect of a structured education intervention, Patient Empowerment Programme (PEP)
patient-reported health-related quality of life (HRQOL) among type 2 diabetes mellitus (T2DM) patients, and if positive
effect is confirmed, to further explore any association between frequency of sessions attendance and HRQOL.
Methods: A total of 298 T2DM patients were recruited when they attended the first session of PEP, between
March and September 2010, and were followed over a one-year period from baseline. HRQOL data were assessed
using Short Form-12 Health Survey version 2 (SF-12) and Short Form-6 Dimension (SF-6D) at baseline and one-year
follow-up. Individuals’ anthropometric and biomedical data were extracted from an administrative database in Hong
Kong. Unadjusted and adjusted analyses of linear regression models were performed to examine the impact of PEP
session attendance on the change in the HRQOL scores, accounting for the socio-demographic and clinical
characteristics at baseline.
Results: Of the 298 eligible patients, 257 (86.2 %) participated in the baseline assessment and 179 (60.1 %) patients
completed the follow-up assessment, respectively. Overall, PEP resulted in a significant improvement in SF-12 bodily
pain and role emotional subscales and SF-6D utility scores. These positive changes were not associated with the level
of participation as shown in both unadjusted and adjusted analyses.
Conclusions: The PEP made significant improvement in bodily pain, role emotional and overall aspects of
HRQOL. Higher number of session attendance was not associated with improvement in HRQOL in primary
care real-world setting.
Key Messages
● Participants with type 2 diabetes mellitus who participated in structured diabetes education programme
made significant improvement in bodily pain and role emotional subscales and SF-6D scores.
● There was no association between the number of sessions attended and any aspect of HRQOL.* Correspondence: carlosho@hku.hk
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Diabetes mellitus is a chronic disease that affects not
only the physical well-being of patients but also their
quality of life [1]. The presence of diabetes-related com-
plications, especially those of greater severity, is associ-
ated with worsened quality of life for patients with type
2 diabetes mellitus (T2DM) [2, 3]. There is also evidence
to suggest that diabetes patients are prone to develop
psychosocial problems, such as anxiety and depression
[4, 5]. Improving patients’ health-related quality of life
(HRQOL) is therefore one of the main goals of diabetes
care as well as patient education [6].
Patient empowerment or self-management interven-
tions have evolved from a didactic approach to one that
needs theoretical foundation. This reflects the increasing
concern for addressing individuals’ underlying beliefs
and attitudes which are considered important for sus-
taining self-care practices and improving long-term out-
comes [7, 8]. In assessing the effectiveness of these
interventions in diabetes and other chronic diseases,
patient-reported HRQOL is increasingly being used as
an outcome measure to evaluate physical, emotional and
social well-being which are not captured in conventional
clinical outcomes [1].
There is a paucity of high-quality data on the impact
of these interventions on the HRQOL of diabetes pa-
tients, as the vast majority of related studies measure
metabolic control and cardiovascular risk reduction but
few included any patient reported outcomes. In a meta-
analysis of studies on group-based diabetes education
intervention published as in 2008, only three studies in-
cluded HRQOL as an outcome were identified [9].
Significant improvement was noted in two out of the three
studies [10, 11]; one study found improvements in the
subscales but not in the overall HRQOL [12]. Due to the
small number of studies and their heterogeneous study
tools, the authors concluded that there was insufficient
evidence regarding the effectiveness of self-management
in improving HRQOL.
The more recent randomised controlled trials inves-
tigating the impact of diabetes education on HRQOL
also yielded mixed results. The DESMOND study
conducted in the UK evaluated the effectiveness of a
structured group education program in 824 patients
with newly diagnosed T2DM [13]. The investigators
found no significant differences in any of the scores
for six dimensions of HRQOL (two overall scores and
four subscale scores for physical, psychological, social, and
environmental) between the intervention and control
groups at one-year follow-up. Another trial in the US
compared group education, individual education and
usual care in 623 adult patients with T2DM [14], and
showed that at a mean follow-up of 6.8 months, HRQOL
improved significantly with individual education, butremained unchanged with group-based education versus
usual care. Previous studies mainly explored clinical bene-
fits of diabetes education intervention and the factors
associated with the attendance of such intervention [15]
but none has investigated the effects of its attendance pat-
tern on the patient-reported outcomes. Cost-effectiveness
analyses utilizing preference-based HRQOL data [16, 17]
address whether structured diabetes intervention was
cost-effective compared with usual care.
The design of Patient Empowerment Programme (PEP),
a structured group-based self-management education pro-
gram for T2DM in primary care setting, and results of its
long-term effects on metabolic control, diabetes-related
complications and mortality have been described else-
where [18–21]. The aims of this study were to exam-
ine whether the PEP improved HRQOL in patients
with T2DM, whether increase in the number of sessions
attended led to better HRQOL, and which compo-
nents (generic versus diabetes-specific component) of
the interventions were associated with better HRQOL
outcomes.
Methods
This was a before-and-after study that evaluated the
change in HRQOL from baseline to year 1 following
PEP intervention. The PEP was launched in 2010 for the
purpose of enhancing the quality of chronic disease
management in primary care throughout Hong Kong.
The aims of the programme were to provide the diabetic
patients with a combination of knowledge, skills and
heighted self-awareness regarding their own disease con-
ditions in order to improve their self-esteem, overall
health outcome and quality of life. In brief, two non-
government organizations (NGOs), highly experienced
in community medical service and education, were in-
vited to conduct the program in the first year. The
programme covered two main aspects (1) generic self-
efficacy enhancement and lifestyle modification compo-
nent and (2) disease-specific knowledge and skills
component. Generic component sessions, with a total
duration of usually 8–10 hours (equivalent to 4–5
two-hour sessions), cover the importance of self-
management and behaviour modification, healthy diet
and regular exercise goal setting and problem-solving
skills, sharing on self-monitoring experience, stress
coping management, psychosocial support and net-
working, and communications with healthcare profes-
sionals. Each generic component was group-based
with a maximum of 30 participants, and was delivered
by the well-trained allied health care professionals,
mainly social workers and dietitians. Each disease-
specific component was delivered by experienced
nurses through lecture-based learning sessions covering
comprehensive information about diabetes, responsibility
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and contingency management on hypo- and hyper-
glycaemia. Total duration of disease-specific sessions is
5 hours, with 2.5 hours per session. There is no limita-
tion on the number of generic component sessions
attended within six months from the date of enrolment,
but the disease-specific sessions were limited to two
sessions for each enrolled patient. The educational re-
sources and curriculum were designed by the clinicians
and nurses and were revised and updated regularly in
order to tailor the material for the diabetic patients in
Hong Kong.
PEP participants
A total of 298 adult individuals selected by convenience
sampling were recruited into this HRQOL study at the
time when the patients attended the first session of PEP
from Hong Kong East and New Territory East district
cluster in Hong Kong, between 1 March 2010 and 30
September 2010. Majority (257, 86.2 %) were T2DM
patients, attended either generic or diabetes-specific
sessions, and completed the baseline assessment by
telephone within one month from the date of recruit-
ment. Respondents were administered with the socio-
demographic questions and HRQOL instruments using
the Chinese (Hong Kong) version of SF-12v2 at baseline
assessment and at 12-month follow-up by telephone.
The HRQOL data were linked with the clinical data in-
cluding anthropometric and laboratory data extracted
from a clinical management system database of the
Hong Kong Hospital Authority. The integration of
HRQOL data with clinical data provided a comprehen-
sive profile of patients’ health, and validated the diagno-
sis of T2DM with the primary care physician coding
International Classification of Primary Care (ICPC-2)
of T90 Diabetes non-insulin dependent.
We defined the patients as having hypertension and
the presence of diabetic complications according to the
diagnosis coding system of International Classification
of Diseases, Ninth Edition, Clinical Modification (ICD-9-
CM) and ICPC-2 in Hospital Authority administrative
database. An information letter detailed the study aims,
and written informed consent was obtained from all PEP
participants. Ethics approval of this study was granted
by the institutional review board.
HRQOL measures
The Chinese (Hong Kong) SF-12 Health Survey has been
validated [22] and normed [23] on the general Chinese
population in Hong Kong, and thus was used to measure
generic HRQOL in the same population with diabetes
[24]. It measures eight subscales of HRQOL on physical
functioning (PF), role physical (RP), bodily pain (BP),
general health (GH), vitality (VT), social functioning(SF), role emotional (RE) and mental health (MH) on a
subscale with theoretical range from 0 to 100. A higher
score indicates better HRQOL, with a norm-based mean
of 50 and standard deviation of 10. The eight subscale
scores were aggregated based on population-specific
weights to calculate two summary scores, the physical
(PCS) and mental component summary (MCS) scores.
The SF-6D is a preference-based measure of health [25],
with a six-dimensional health state classification (physical
health, role limitation, bodily pain, vitality, mental health,
and social functioning) that quantifies a patient’s health
for each dimension, and a set of preference-based weights
obtained from representative samples of general popula-
tion. By deriving the SF-6D preference-based score, seven
out of twelve items from SF-12 has been selected to retain
the minimum loss of descriptive information as described
by Brazier and colleagues [26]. The SF-12-derived SF-6D
preference-based score was responsive to detect HRQOL
improvements over time [27], with theoretical plaus-
ible range from 0.315 (the worse possible health state)
to 1 (full health), according to Chinese Hong Kong
population-specific scoring algorithm [28, 29]. The
clinically important difference of SF-6D was regarded
as a difference of at least 0.051 [30]. Based on avail-
able SF-6D preference-based data, the quality-adjusted
life-year (QALYs) can be estimated for cost-effectiveness
analysis of PEP in economic evaluation.
Sample size calculation
According to a meta-analysis [9] of three previous studies,
effect size for overall HRQOL outcome of 0.31 was re-
ported. Based on an alpha value of 5 % and power of 80 %,
a total of 90 patients were needed to detect the change in
HRQOL scores from PEP enrolment at baseline to 12-
month follow-up by paired t-test with moderate effect size
of 0.3.
Data analysis
Descriptive statistics were used to calculate the baseline
characteristics of socio-demographic and clinical data in
respondent and non-respondent groups. Differences in
baseline characteristics between respondent and non-
respondent groups were tested using Mann–Whitney U-
test for continuous variables or Chi-square test for
categorical variables.
We assessed the effects of PEP on HRQOL over time
with the HRQOL scores by SF-12 and SF-6D measured at
baseline and follow-up. Unadjusted analyses on the
changes in HRQOL scores at follow-up from baseline were
tested using paired t-test. Adjusted analyses of the linear
regression models were performed to estimate the number
of PEP session attendance on the change in HRQOL
scores, accounting for the socio-demographic characteris-
tics and clinical data collected at baseline assessment.
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Version 12.0. All significance tests were two-tailed and
those with a p-value less than 0.05 were considered sta-
tistically significant.
Results
Of 298 PEP participants who agreed to join the study,
257 (86.2 %) eligible patients participated in the baseline
assessment and 179 (60.1 %) completed the 12-monthTable 1 Baseline Characteristics of Respondents and Non-responden
Total
Characteristic (N = 298)
Socio-demographic
Age (year, Mean ± SD) 62.0 ± 9.6
Sex (n, %)
Male 147 (49.3 %)
Female 151 (50.7 %)
Smoking status (n, %)
Non-smoker 223 (76.1 %)
Ever smoking 70 (23.9 %)
Alcohol status (n, %)
non-drinker 208 (71.0 %)
Ever drinking 85 (29.0 %)
Educational level (n, %)
Secondary or below 17 (5.8 %)
Tertiary or above 276 (94.2 %)
Clinical
Biometric Data (Mean ± SD)
Weight (kg) 65.3 ± 12.1
BMI (kg/m2) 25.7 ± 3.7
Waist (cm) 90.4 ± 9.7
HbA1c (%) 7.2 ± 1.2
SBP (mmHg) 135.9 ± 17.0
DBP (mmHg) 77.2 ± 11.2
LDL-C (mmol/L) 2.8 ± 0.8
TC (mmol/L) 4.7 ± 0.9
HDL-C (mmol/L) 1.3 ± 0.3
TG (mmol/L) 1.5 ± 0.9
Duration of DM (year, Mean ± SD) 7.3 ± 5.9
Diabetic complication (n, %) 11 (3.7 %)
Hypertension (n, %) 238 (79.9 %)
Treatment Modality (n, %)
Diet only 31 (10.4 %)
Oral and/or insulin treated 267 (89.6 %)
Note:
HbA1c Haemoglobin A1c, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure,
Cholesterol, TG Triglycerides
*Statistically different (P < 0.05) between PEP and non-PEP groups by independentfollow-up assessment. Baseline characteristics of PEP re-
spondents and non-respondents are summarized in
Table 1. There were no significant differences in any
baseline characteristics between the respondents and
non-respondents.
Table 2 presents the descriptive statistics of HRQOL
from baseline to 12-month assessment. In general, the
PEP participants reported significant improvement in
bodily pain, role emotional subscale and SF-6D scores atts in PEP Participants
Respondents Non-respondents
(N = 257) (N = 41) P-value*
61.7 ± 9.6 63.6 ± 9.6 0.250
0.204
123 (47.9 %) 24 (58.5 %)
134 (52.1 %) 17 (41.5 %)
0.535
191 (75.5 %) 32 (80.0 %)
62 (24.5 %) 8 (20.0 %)
0.821
179 (70.8 %) 29 (72.5 %)
74 (29.2 %) 11 (27.5 %)
0.051
12 (4.7 %) 5 (12.5 %)
241 (95.3 %) 35 (87.5 %)
65.5 ± 12.4 63.6 ± 10.3 0.363
25.7 ± 3.7 25.1 ± 3.6 0.332
90.6 ± 9.8 88.8 ± 9.7 0.297
7.3 ± 1.2 7.1 ± 0.9 0.495
136.2 ± 17.4 134.1 ± 14.2 0.456
77.2 ± 11.6 76.8 ± 8.9 0.830
2.9 ± 0.8 2.8 ± 0.8 0.806
4.7 ± 0.9 4.8 ± 1.1 0.747
1.3 ± 0.3 1.3 ± 0.4 0.873
1.5 ± 0.9 1.8 ± 1.0 0.091
7.3 ± 6.0 7.3 ± 5.5 0.981
10 (3.9 %) 1 (2.4 %) 0.647
207 (80.5 %) 31 (75.6 %) 0.464
0.884
27 (10.5 %) 4 (9.8 %)
230 (89.5 %) 37 (90.2 %)
LDL-C Low Density Lipoprotein – Cholesterol, BMI Body Mass Index, TC Total
t-test or Chi-square test, where appropriate







Change over Time (n = 179)
HRQOL Mean 95%CI P-value*
SF-12v2
PF 87.3 ± 22.9 88.3 ± 20.1 1.2 ± 21.5 (−1.9, 4.4) 0.440
RP 89.5 ± 20.1 89.5 ± 20.5 −0.1 ± 20.7 (−3.1, 3.0) 0.964
BP 81.4 ± 28.7 86.0 ± 23.9 6.0 ± 28.5 (1.9, 10.2) 0.005
GH 40.7 ± 25.0 36.5 ± 23.7 −3.6 ± 29.2 (−7.9, 0.6) 0.095
VT 71.3 ± 26.5 74.0 ± 17.5 3.7 ± 25.5 (0.0, 7.4) 0.052
SF 91.3 ± 21.2 92.3 ± 19.3 1.0 ± 22.1 (−2.3, 4.2) 0.560
RE 88.5 ± 19.1 90.8 ± 16.3 2.7 ± 16.9 (0.2, 5.1) 0.034
MH 79.9 ± 18.1 81.0 ± 15.9 0.5 ± 17.2 (−2.1, 3.0) 0.706
PCS 49.1 ± 8.9 49.0 ± 7.7 0.4 ± 8.5 (−0.9, 1.6) 0.548
MCS 56.4 ± 9.5 57.2 ± 7.4 0.8 ± 8.7 (−0.5, 2.1) 0.229
SF-6D 0.847 ± 0.148 0.869 ± 0.135 0.026 ± 0.124 (0.008, 0.044) 0.006
Note:
PEP = Patient Empowerment Programme; HRQOL = Health-related Quality of Life; PF = Physical Functioning; RP = Role Physical; BP = Bodily Pain; GH = General
Health; VT = Vitality; SF = Social Functioning; RE = Role Emotional; MH =Mental Health; PCS = Physical Composite Summary; MCS =Mental Composite Summary
*P-value of testing significance in mean changes using paired t-test
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not clinically significant, improvement in SF-6D (0.026 ±
0.124, P = 0.006) was observed. The changes in HRQOL
stratified by total number of PEP session attended are
shown in Table 3. One-session attendees reported deteri-
oration in all HRQOL subscales except bodily pain and vi-
tality subscale scores, at the 12-month follow-up; whilst
positive changes in all HRQOL subscales but general
health were observed in frequent attendees (≥7 ses-
sions). Of the 179 remaining patients who attended ei-
ther generic or diabetes-specific sessions, 156 (87.2 %)
attended at least one session and were defined as generic
session attendees while there were 150 (83.8 %) diabetes-
specific session attendees. At 12-month, the change in
mean SF-6D was numerically higher albeit insignificant in
attendees of diabetes-specific sessions than non-attendees
(0.033 ± 0.120 vs −0.011 ± 0.138, P = 0.077), and the im-
provement in SF-6D in generic session attendees was not
as significant as that of non-attendees (0.017 ± 0.124 vs
0.086 ± 0.109, P = 0.012). There was no change in the
mental aspect of HRQOL associated with the number of
attendance at the generic sessions (0.9 ± 8.8 vs −0.3 ± 8.5,
P = 0.517) and diabetes-specific sessions (0.9 ± 8.5 vs 0.4 ±
9.8, P = 0.781). Diabetes-specific session attendees had sig-
nificantly better scores in the physical aspect of HRQOL
than non-attendees (1.0 ± 8.6 vs −2.7 ± 7.3, P = 0.032) while
association between physical aspect of HRQOL and num-
ber of generic sessions attended was found to be insignifi-
cant (P = 0.073). Across other HRQOL subscales of SF-12,
the diabetes-specific session attendees reported higher
physical scores (−9.6 ± 24.5 vs 1.8 ± 19.4, P = 0.006) than
non-attendees. The generic session attendees had lowerbodily pain scores (19.6 ± 31.9 vs 4.1 ± 27.5, P = 0.015) than
those who did not attend the generic sessions. However,
the HRQOL were not associated with the total number of
PEP sessions attended in both the unadjusted analysis and
adjusted analysis when fully adjusted for the baseline
characteristics.
Discussions
In this study we evaluated the effect on HRQOL at one-
year of the PEP, delivered in a primary care setting as
structured group-based diabetes education intervention
by NGOs.
HRQOL outcomes after PEP
Although there were no significant changes in most of
the HRQOL subscales at the 12-month follow up, sub-
scales of bodily pain and role emotional were significantly
improved among the PEP participants. This is inconsistent
with findings from major randomized controlled trials
assessing the one-year effect of group-based structured
self-management education intervention on patient-
reported outcomes [12, 31, 32]. In a US study, the physical
aspect of HRQOL was also found to be unchanged at
about seven months after enrollment of diabetes group
education while the mental aspect of HRQOL was wors-
ened [14]. The Expert Patient Education (X-PERT) pro-
gram for group-based self-management intervention for
T2DM showed a positive effect of the intervention on the
diabetes-specific HRQOL [12] whilst the physical function-
ing of HRQOL sustained improvements after 12 months
[31]. In the ongoing DESMOND intervention delivered in
primary care setting [33] and the ROMEO intervention
Table 3 Health-related Quality of Life according to the number of PEP session attendance
PEP session attendance
HRQOL 1 (n = 25) 2 (n = 49) 3-6 (n = 41) ≥7 (n = 64) P-value*
Change in SF-12v2
PF −3.8 ± 16.9 3.5 ± 21.4 2.3 ± 21.0 0.8 ± 23.6 0.546
RP −7.2 ± 23.2 1.3 ± 15.0 −2.3 ± 17.9 3.3 ± 24.4 0.137
BP 8.7 ± 33.1 13.5 ± 27.8 −1.2 ± 22.7 3.9 ± 29.6 0.081
GH −11.7 ± 25.3 0.1 ± 24.8 −5.6 ± 33.8 −2.0 ± 30.4 0.360
VT 1.9 ± 27.3 4.0 ± 23.9 1.8 ± 27.3 5.5 ± 25.4 0.881
SF −3.8 ± 32.9 0.0 ± 12.4 −1.7 ± 18.4 5.5 ± 24.6 0.203
RE −1.0 ± 16.6 5.5 ± 14.3 −2.0 ± 15.9 5.1 ± 18.9 0.063
MH −4.0 ± 23.0 3.3 ± 14.4 −1.5 ± 14.1 1.4 ± 18.4 0.294
PCS −1.5 ± 9.2 1.9 ± 7.7 −0.4 ± 7.0 0.4 ± 9.5 0.374
MCS −0.8 ± 10.8 1.3 ± 6.9 −0.9 ± 7.7 2.1 ± 9.6 0.249
Change in SF-6D 0.000 ± 0.139 0.064 ± 0.106 0.001 ± 0.110 0.024 ± 0.134 0.059
Generic session attendance DM-specific session attendance P-value**
Non-attendees Attendees Non-attendees Attendees
DM-specificHRQOL 0 (n = 23) ≥1 (n = 156) 0 (n = 29) ≥1 (n = 150) Generic
Change in SF-12v2
PF 4.3 ± 19.4 0.8 ± 21.8 −5.0 ± 15.3 2.5 ± 22.4 0.458 0.083
RP 3.3 ± 10.1 −0.5 ± 21.8 −9.6 ± 24.5 1.8 ± 19.4 0.411 0.006
BP 19.6 ± 31.9 4.1 ± 27.5 5.0 ± 26.6 6.3 ± 29.0 0.015 0.827
GH 0.4 ± 17.5 −4.2 ± 30.5 −7.7 ± 27.2 −2.8 ± 29.5 0.476 0.408
VT 3.3 ± 23.0 3.8 ± 26.0 −1.7 ± 26.2 4.8 ± 25.4 0.929 0.208
SF −4.3 ± 9.7 1.7 ± 23.3 −3.3 ± 31.3 1.8 ± 19.9 0.220 0.247
RE 2.7 ± 10.6 2.7 ± 17.6 −2.1 ± 19.7 3.6 ± 16.2 0.987 0.093
MH 2.7 ± 17.7 0.2 ± 17.2 1.3 ± 22.2 0.3 ± 16.2 0.508 0.784
PCS 3.3 ± 7.3 −0.1 ± 8.6 −2.7 ± 7.3 1.0 ± 8.6 0.073 0.032
MCS −0.3 ± 8.5 0.9 ± 8.8 0.4 ± 9.8 0.9 ± 8.5 0.517 0.781
Change in SF-6D 0.086 ± 0.109 0.017 ± 0.124 −0.011 ± 0.138 0.033 ± 0.120 0.012 0.077
Note:
PEP Patient Empowerment Programme, HRQOL Health-related Quality of Life, PF Physical Functioning, RP Role Physical, BP Bodily Pain, GH General Health,
VT Vitality, SF Social Functioning, RE Role Emotional, MH Mental Health, PCS Physical Composite Summary, MCS Mental Composite Summary
*P-value of testing significance using one-way ANOVA
**P-value of testing significance between non-attendees and attendees using paired t-test
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and continued to improve beyond the first year.
Associations of PEP sessions attended with HRQOL
outcomes
One of the priori hypotheses was that frequent PEP
session attendees were beneficial from the greater level
of HRQOL. In general, intensive interventions with
more training sessions and a longer duration yielded
greater improvement for knowledge and metabolic con-
trol, but this did not necessarily apply to self-management
behaviours [35]. It is important to highlight that PEP
reflected real world situations, different from clinical trials
unlike the DESMOND [13, 33] and X-PERT [12]. Basedon conceptual framework for diabetic patients proposed
by Rubin and Peyrot [1], the HRQOL is affected by not
only clinical factors but also modifiable psychosocial fac-
tors such as health beliefs, social support, and coping
strategies. PEP participants may have coped with diseases
more actively, and a greater degree of health beliefs and
social support, thereby leading to HRQOL improvement
after 12-month. However, increased attendances of two
education components, regardless of generic and diabetes-
specific components, were not associated with better
HRQOL with respect to the physical and mental aspects
of SF-12. On the contrary, the patients attended more
than five sessions of generic sessions were associated with
lower SF-6D scores. As each participant is expected to
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that in generic sessions excessive (>5) attendance of
the programme appeared to have a negative impact on
SF-6D. Findings of current study allowed the translation
of SF-6D preference-based score to QALYs for the sub-
sequent use in economic evaluation. Future studies on the
cost-effectiveness analysis of PEP should impose the
quality adjustment for PEP participants with respect to
the number of sessions attended.
The negative findings were thought to be in part
attributable to the poor associations of knowledge and
information transferred with the behaviour modifica-
tions [8]. Even when the PEP sessions were voluntary,
over-exposure of generic information learnt by partici-
pants could be somewhat counter-productive and fear-
inducing [8] leading to the poor compliance of behavior
modifications and negative impact on patient-reported
outcomes. Furthermore, benefits of improved clinical out-
comes from the PEP intervention were not necessarily im-
plied to the positive impact on patient-reported outcomes.
The insignificant change in HRQOL following the educa-
tion intervention is often regarded as ‘positive’ [7], in part
due to the increased feelings of stress and burden.
By using the PEP as an example, increasing the sessions
attended was not associated with improved HRQOL in
participating structured diabetes education intervention.
Other than education session attendance, strengthening
other intervention components such as incorporating
regular reinforcement, appropriate duration of interven-
tion, delivery of booster sessions, peer support or health
educator support, may provide alternative ways of de-
livering effective diabetes education interventions [35–37].
Further research is needed to determine the important
components that should be included in the patient
empowerment paradigm [35], and to tailor structured
education interventions to those receiving the greatest
benefits and those in need.
Limitations
Limitations of this study should be noted. First, there
may be concerns of generalizability and response bias
with the small proportion of PEP participants included in
the study. For instance, a higher proportion of female par-
ticipants were found in respondent group when compared
non-respondent group. Moreover, the negativity bias may
be demonstrated in non-respondents whom did not re-
spond at 12-month follow-up, leading to potential differ-
ences between respondents and non-respondents in the
outcomes being measured. However, baseline characteris-
tics between respondent and non-respondents showed no
significant differences. Secondly, the nature of before-and-
after study was unlikely to compare with patients without
participation of PEP as control group. We cannot rule out
possibility that observed changes in HRQOL may beinfluenced by general trends in routine clinical practice or
other unadjusted clinical factors such as onset of diabetic
complications. However, our previous studies [19, 20] re-
ported that there were low annual incidence rates of de-
veloping diabetic complications in PEP group, supporting
that the changes in HRQOL scores were mainly due to
the PEP participation.Conclusions
There were no associations between the number of ses-
sions attended and any aspect of HRQOL. Based on the
changes in HRQOL outcomes, the increase in the ses-
sions attended was not associated with better HRQOL
in participants attending structured diabetes education
intervention in real-world setting. Understanding such
associations can enhance our ability to make structural
diabetes education intervention more effective and cost-
effective by setting out the ceiling of sessions attended.
Nevertheless, the impact on clinical outcomes should
also take into consideration for the recommendation to
the threshold for the optimal number of PEP session to
be attended.
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